期刊文献+

特发性血小板减少性紫癜发病机制的研究现况 被引量:4

Research Progress of Idiopathic Thrombocytopenic Purpura
在线阅读 下载PDF
导出
摘要 特发性血小板减少性紫癜(ITP)是一种常见的出血性自身免疫病,其发病机制尚未完全明了。目前认为ITP的原因主要是人体自身免疫耐受机制被打破,体液免疫和细胞免疫紊乱,导致血小板破坏增加和(或)生成障碍。淋巴细胞是维持机体免疫功能的主要细胞群,其凋亡和增殖平衡被打破,就会导致免疫功能紊乱,进而形成自身免疫性疾病。本文对特发性血小板减少性紫癜发病机制的研究现况予以综述。 Idiopathic thrombocytopenic purpura(ITP) is a common hemorrhagic autoimmune disease,but the pathogenesis remains unclear. ITP is mainly caused by the broken immune tolerance and the increase of platelet destruction and/or generate obstacles. Lymphocytes are the major ceil groups in maintaining the immune function. The balance between apoptosis and proliferation of lymphocytes is broken in vivo,which causes the immune function disorders and autoimmune diseases. This article reviewed the research progress of ITP.
出处 《医学综述》 2009年第15期2277-2280,共4页 Medical Recapitulate
关键词 血小板减少性紫癜 特发性 发病机制 感染 免疫 Thrombocytopenic purpura Idiopathic Pathogenesis Infection Immunity
  • 相关文献

参考文献31

  • 1Wright JF,Blanchette VS,Wang H,et al.Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytoponic purpura (ITP)[J].Br J Haematol,1996,95(1):145-152.
  • 2Pipp ML,Means ND,Sixbey JW,et al.Acute Epstein-Barr virus infaction complicated by severe thrombocytopenia[J].Clin Infect Dis,1997,25(5):1237-1239.
  • 3Musaji A,Cormont F,Thirion G,et al.Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses[J].Blood,2004,104(7):2102-2106.
  • 4Tanaka M,Kamijo T,Koike K,et al.Specific autoantibodies to platelet glycoproteins in Epstein-Barr virus-associated immune thrombocytopenia[J].Int J Hematol,2003,78 (2):168-170.
  • 5Ding Y,Zhan L,Mei H,et al.Role of mycloid human cytomcgalovirus infection in children's idiopathic thrombocytopenic purpura[J].Pediatr Hematol Oncol,2007,24(3):179 -188.
  • 6Gasbarrini A,Franceschi F,Tartsglione R.Regression of autoimmune thrombocytopenia after eradication of helicobacter pylori[J].Lancet,1998,352(9131):878-878.
  • 7Tohda S.Resolution of refractory idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori[J].Am J Hematol,2000,65(4):329-330.
  • 8Ando K,Shimamoto T,Tauchi T,et al.Can eradication therapy for heliobacter pylori really improve the thrombocytoenia in idiopathic thrombocytopenic pupura?[J].Int J Hematol,2003,77(3):239-244.
  • 9Franchini M,Cruciani M,Mcngoli C,et al.Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura:a systematic review and meta-analysis[J].J Antimicrob Chemother,2007,60(2):237-246.
  • 10Estrada-Gomez RA,Parra-Ortega I,Martinez-Barreda C,et al.Helicubacter pylori infection and thrombocytopenia:a single-institution experience in Mexico[J].Rev Invest Clin,2007,59(2):112-115.

二级参考文献20

  • 1高清平,姜建昌,曾艳,王巧玲,陈友华,敖绪斌,陈伦华,杨年兰,王琼玉,张克俭,姚春.慢性特发性血小板减少性紫癜患者B淋巴细胞的研究[J].中华血液学杂志,2004,25(11):687-688. 被引量:10
  • 2伍昌林,刘仿,肖红,陈群,杨小猛.特发性血小板减少性紫癜患儿外周血T细胞凋亡信号蛋白表达的临床意义[J].实用儿科临床杂志,2005,20(9):885-887. 被引量:5
  • 3Fang Liu~(1,2) Changlin WU~1 Xiaomeng Yang~1 Hong Xiao~1 Xuemin Zhuo~1 Zhengwei Cheng~1 Qun Chen~1 ~1Department of Microbiology and Immunology,Guangdong Medical College,Zhanjiang,Guangdong 524023,China,~2Department of Microbiology and Immunology,Guangdong Medical College,No.2 Wen-ming East Road,Zhanjiang,Guangdong 524023,China..Polarization and Apoptosis of T Cell Subsets in Idiopathic Thrombocytopenic Purpura[J].Cellular & Molecular Immunology,2005,2(5):387-392. 被引量:5
  • 4马廉,肖升平.特发性血小板减少性紫癜的诊断和治疗[J].实用儿科临床杂志,2006,21(3):185-188. 被引量:18
  • 5Zipp F,Martin R,Liehtenfels R,et al. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. J Immunol. 1997.159:2108 - 2115.
  • 6Smdoray P, Jellestad S, Nakkea B, et al. Programmmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry. Lab Invest, 2003,83 : 1839 - 1848.
  • 7Umezawa k,Ariga A, Matsumoto N,et al. Naturaly occurring and synthetic inhibitors of Nr2KB functions. Anticancer Drug Des, 2000,15 :239 - 244.
  • 8Ju S T, Pomka D J, Cui H et al. Fas (CD95)/FasL interaction required for progaunmed cell death after T-cell activation. J Nature, 1995,373:444 - 4448.
  • 9Yoshimura C,Nomura S,Nagahama M ,et al. Plasma - soluble Fas( APO - 1 ,CD95 ) and soluble Fas ligand in immune thrombocytopenic purpura. Eur J Haematol,2000 ,64 :219 - 224.
  • 10Anolik J,Sanz I. B cells in human and murine systemic lupus erythema-tosus. Curr Opin Rheumatol. 2004,16:505 - 512.

共引文献38

同被引文献45

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部